Biotech, Food & Drug

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Nov
2
2020
California Federal Judge Dismisses First Amended Complaint in Proposed Class Action Against Kellogg Vanilla Labeling Keller and Heckman LLP
Oct
30
2020
Proposed Class Action Lawsuit Targets Crackers Labeled as “Butter” Flavored Although they Contain Vegetable Oils Keller and Heckman LLP
Oct
29
2020
New York’s Long-Awaited Hemp Cannabinoid Rules May Create a Consumer-Friendly National Model Wilson Elser Moskowitz Edelman & Dicker LLP
Oct
29
2020
Cookie Trade Dress Infringement Case Crumbles in Face of Functionality Challenge McDermott Will & Emery
Oct
29
2020
Healthcare: Anticompetitive Tying Class Action Moves Forward Against Sutter Health MoginRubin
Oct
29
2020
Pharmaceutical Price Reduction Approaches Giordano, Halleran & Ciesla, P.C.
Oct
29
2020
Pharma: Consumer Groups, States Support Reviving Generic Drugs Antitrust Case Against AbbVie MoginRubin
Oct
27
2020
Brexit and COVID-19: Changes to the Regulation of Medicines McDermott Will & Emery
Oct
27
2020
FDA Holds Webinar on The First 100 Days: New Era of Smarter Food Safety Keller and Heckman LLP
Oct
27
2020
Brazilian Institute Proposes Revised Chemical Classification, Labeling, and Hazard Communication Standard Beveridge & Diamond PC
Oct
26
2020
China Solicits Comments on Food-Contact Substances Keller and Heckman LLP
Oct
26
2020
NNI Strategic Planning Stakeholder Workshop Will Be Held in January 2021 Bergeson & Campbell, P.C.
Oct
26
2020
Price Gouging Weekly Round Up: October 26, 2020 Proskauer Rose LLP
Oct
26
2020
FDA Announces a One Year Pilot Program to Evaluate Third-Party Food Safety Standards and Invites Requests to Participate Keller and Heckman LLP
Oct
26
2020
California Governor Signs Law that Establishes New Safety Standards for Third-Party Food Delivery Applications Keller and Heckman LLP
Oct
23
2020
EFSA Updates Opinion on Styrene in FCMs Keller and Heckman LLP
Oct
22
2020
Japan Announces Process for Adding “Existing Substances” to PL Keller and Heckman LLP
Oct
22
2020
FDA Requests Comments on Labeling Cell-Cultured Seafood Products Beveridge & Diamond PC
Oct
22
2020
China Publishes New Draft GB Standards Related to Food-Contact Materials and Articles Keller and Heckman LLP
Oct
22
2020
Conventional and Cell-Based/Cultured Meat Groups Write Joint Letter to USDA Urging Agency to Solicit Input on What Labeling Should Look Like Keller and Heckman LLP
Oct
22
2020
Gaps in Payment for COVID-19 Laboratory Testing Plague Providers and Patients Polsinelli PC
Oct
21
2020
Drug Manufacturers Unlawfully Target 340B Program Reductions Polsinelli PC
Oct
21
2020
Got COVID-19 “Claims”: Recent US EPA Enforcement under FIFRA Emphasizes Compliance Demands on Pesticide Product Supply Chains, especially for Products Claiming to be Effective against Coronavirus Hunton Andrews Kurth
Oct
20
2020
Bioethics in a Pandemic: Final Framework for Equitable Allocation of a COVID-19 Vaccine Mintz
Oct
20
2020
California Governor Pulls the Plug on Genetic Information Privacy Act Sheppard, Mullin, Richter & Hampton LLP
Oct
20
2020
Study Finds Surge In Misuse of Fentanyl, Heroin and Nonprescribed Opioids During COVID-19 Pandemic Jackson Lewis P.C.
Oct
20
2020
Conagra Slips Away from Parkay Oil Spray Serving Size Claims Proskauer Rose LLP
Oct
20
2020
FDA Announces Establishment of U.S. Agent Voluntary Identification System Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins